Brief: Crescita Therapeutics™ Reports Qtrly Net Loss From Continuing Operations Per Share $0.03
09/05/2018 12:45
May 9 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS™ REPORTS 2018 FIRST QUARTER RESULTS
* CRESCITA THERAPEUTICS INC QTRLY NET LOSS FROM CONTINUING
OPERATIONS PER SHARE $0.03
Source text for Eikon: ID:nCNW72YpMa
Further company coverage: CTX.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium